Influence of body mass index and age on the grade of hair growth in hirsute women of reproductive ages*
|
|
- Dorcas Barnett
- 5 years ago
- Views:
Transcription
1 FERTILITY AND STERILITY Copyright 1988 The American Fertility Society Vol. 50, No. 2, August 1988 Printed in U.S.A. Influence of body mass index and age on the grade of hair growth in hirsute women of reproductive ages* Kristiina Ruutiainen, M.D. t+ Risto Erkkola, M.D.t Matti A. Gronroos, Ph.D. Kerttu Irjala, M.D. II Turku University Central Hospital and Turku University, Turku, Finland The relationships between the hair growth in different body regions, body mass index (BMI) and age were studied in 225 women of reproductive ages referred for hirsutism. The regularity of the cycles was registered, and 109 of the patients were interviewed for their maximum weight, teenage obesity, and age of menarche. The serum androgens were measured in the follicular phase. The results indicate that facial hirsutism is associated with BMI (p = 0.41, P < ) independently of age and the testosterone (T) to sex hormone-binding globulin (SHBG) ratio. Facial hirsutism is also correlated with age (p = 0.37, P < ) irrespective of BMI (p = 0.26, P < ) or the T /SHBG ratio (p = 0.43, P < ). In contrast, the hair growth on trunk area is related to the T/SHBG ratio (p = 0.35, P < ) but not to BMI or age when the correlations are adjusted for the grade of hyperandrogenemia. The women with severe facial hirsutism had a higher maximum weight (P < ) and more teenage obesity (P < 0.01) than other hirsute patients. They also had a slightly earlier menarche compared with their agemates than the women with mild or absent facial hair (P < 0.05). The data suggest differencies in the regulation of hair growth between the face and trunk areas. Fertil Steril 50:260, 1988 Hirsutism is associated with increased androgen production rates 1 and with high total and free androgen levels. 2 3 Androgen production and metabolism have been increased in obesity, 4 too, and the low serum concentrations of sex hormone-binding globulin (SHBG) in overweight women 5 result in high levels of biologically active testosterone (T). 6 7 Similarities in androgen metabolism have been considered to suggest an association between obesity and hirsutism. 8 Received August 13, 1987; revised and accepted April5, * Supported by a grant from the Emil Aaltonen Foundation, Tampere, and from the Duodecim Foundation, Helsinki, Finland. t Department of Obstetrics and Gynecology, Turku University Central Hospital. :j: Reprint requests: Kristiina Ruutiainen, M.D., Department of Obstetrics and Gynecology, Turku University Central Hospital, Turku SF-20520, Finland. Department of Statistics, Turku University. II Central Laboratory, Turku University Central Hospital. 260 Ruutiainen et al. Hirsutism, weight and age Based on answers to questionnaires obtained from more than 26,000 premenopausal women, Hartz et al. 9 were able to demonstrate a relationship between obesity and virile hair growth with facial hair. Facial hirsutism was increased with a longer duration of obesity. The androgen profiles of the patients were not studied. In hirsute women of reproductive ages, the serum androgen concentrations are significantly decreased by age. 7 However, more than 20 years ago, Ferriman and Gallwey 10 noticed that the hairiness tended to increase on the face and disappear from other sites with advancing years. Whether this was an aging phenomenon or associated with the increased frequency of obesity in older women was not studied. The present work was undertaken to explore the relationships of hirsutism in different body regions to body mass index (BMI) or age after eliminating the effect of changing androgen levels. Another purpose was to search after possible Fertility and Sterility
2 differences in previous overweight, menstrual pattern, age of menarche, and serum androgen par ameters between patient groups with different localization of virile hair growth. Patients MATERIALS AND METHODS The study group consisted of 229 consecutive premenopausal patients referred for hirsutism. All patients were clinically examined by one of us (KR). Four patients with an adrenogenital syndrome or an androgen-secreting tumor were excluded from consideration. The age of the patients ranged from 17 to 52 years (mean 30.8, standard deviation [SD] 5.2). A complete gynecologic examination was made. Pelvic ultrasound, laparoscopy, computer tomography of the sella and the adrenals, ( 131 l)iodocholesterol scanning of the adrenals, selective catheterization of the adrenal and ovarian veins, and adrenocorticotropin (ACTH) stimulation and dexamethasone suppression tests were made when needed to exclude a possibility of a virilizing tumor. All except one patient had normal cortisol diurnal variations, but she also had normal urine free cortisol secretion. None of the women had true hyperprolactinemia (prolactin [PRL] values< 40 ~g/1), and all were euthyreotic. Ninetyseven of the women had regular menstrual cycles (28 ± 4 days), 41 had slightly irregular cycles (28 ± 7 days), and 83 were oligomenorrheic (menstrual cycles > 35 days). Two young patients who had previously had regular cycles no longer menstruated at the time of the study as they had undergone hysterectomy. The data of menstrual cycles failed in two patients. The terminal hair growth in 11 body regions was graded according to a modification of the criteria of Ferriman and Gallwey. 10 Steps of 0.5 were used, and the scores ranged from 0.0 to 4.0. The body areas defined by Ferriman and Gallwey were grouped as follows: face (regions 1-2), trunk (3-8 and 10), and total (1-11). The quantitation of hirsutism preceded the determination of the laboratory values. The grade of hirsutism on the face area ranged from 0.0 to 8.0 (mean 3.0, SD 2.3); on the trunk area, from 0.0 to 18.0 (mean 6.1, SD 3.6); and on the total body area, from 0.0 to 31.0 (mean 12.6, SD 5.6). BMI, the ratio weight/height 2 was assessed by a nomograph method of Thomas et al. 11 The BMI of the patients ranged from 16 to 49 kg/m 2 (mean 24.6, SD 5.8) and the weight of the women from 43 to 137 kg. The historical data of possible teenage obesity was obtained from 109 women and of the maximum weight of the patient from 90 women. The teenage obesity was defined by the patient herself as follows: 1 = lean or normal weight, 2 = overweight, 3 = very obese. The maximum weight of the women ranged from 46 to 135 kg (mean 79.3, SD 19.9). The historical data of the age of menarche were obtained from 109 women. The patients' menarcheal age ranged from 10 to 20 years (mean 12.7, SD 1.5). The difference between the patient's menarche and the mean age of menarche in the respective age group(.:\ Mage) was calculated by regarding 14 years as the mean of normal menarche in women born 1940 or earlier and 13 years in women born 1941 or later. 12 The difference was expressed in steps of half years, -1 meaning the menarche 1 year earlier and year later than that of the agemates. The patients were divided into groups according to the location of the excessive hair growth. The patients in the group A had pure facial hirsutism with the facial score of terminal hair ::::: 4.0 but with the trunk score of <5.0. The group B consisted of women with male-pattern hair scattered both on the face (score::::: 4.0) and on the trunk (score;;:: 5.0) areas. The females in the group C had their excessive hair growth concentrated on the trunk area (trunk score ::::: 8.0, facial scores; 3.0). Hormone Assays The blood samples collected in the early follicular phase (days 3 to 7) of the menstrual cycle were included (N = 200). In the oligomenorrheic women, the specimens were taken during a progesteronechallenge withdrawal bleeding with dydrogesterone 10 mg/day for 10 daysp The sampling was carried out between 8 A.M. and 9 A.M. The patients had not used any hormonal medication for at least 2 months before the study. The serum values fort, androstendione (A), dehydroepiandrosterone sulfate (DHEAS), SHBG, estradiol (E 2), luteinizing hormone (LH), and follicle-stimulating hormone (FSH) were measured by radioimmunoassay (RIA) as described earlier. 2 The values for A missed in two women and those for SHBG in two other women. The serum T values ranged from 1.1 to 5.5 nmol/1 (mean 2.4, SD 0.7), the serum A values from 2.0 to 20.1 nmol/1 (mean 8.1, SD 3.3), DHEAS from Vol. 50, No.2, August 1988 Ruutiainen et al. Hirsutism, weight and age 261
3 1.6 to 16.8 umol/1 (mean 8.2, SD 3.2), SHBG from 12.0 to nmol/1 (mean 49.1, SD 22.3), and the T/SHBG ratio (10 3 ) from 12.0 to (mean 59.1, SD 33.6). In our laboratory, the normal values are for T 0.8 to 2.5 nmol/1, for A 4.0 to 9.0 nmol/1, for DHEAS 2.0 to 9.0 ~mol/1, and for SHBG 35.0 to nmol/l. Statistical Methods The main part of the statistical analysis was done using BMDP computer program, and the simultaneous statistical inference available in it was utilized. Kruskall-Wallis' analysis of variance, the two-sided Mann-Whitney U-test, and Spearman's rank correlation coefficient were used for the nonparametric statistical calculations. The calculation of partial Spearman's correlation is not straightforward. A rank analogue of partial product-moment correlation coefficient, which is sometimes used, is not even asymptotically distribution free. Instead of it, we used a partial Spearman's rank correlation coefficient proposed by Shirahata. 14 Shirahata 15 showed that the coefficient has good asymptotic properties. RESULTS There was a significant positive correlation between facial hirsutism and BMI (p = 0.41, P <, Table 1) independently of the effect of age or the T /SHBG ratio. The facial hair growth and age were also significantly related (p = 0.37, P <, Table 2) independently of the grade of hyperandrogenemia (p = 0.43, P < after adjusting for the T /SHBG ratio). The association of facial hirsutism to age was, however, to some de- Table 2 The Correlations (Simple and Partial Corrected for the Body Mass Index [BMI] and for the Testosterone/Sex Hormone-Binding Globulin [T/SHBG] Ratio) Between the Hair Growth and the Age Hirsutism score Face Trunk Total Simple (N = 223) b NSd p < b p < c p <. d NS, not significant. Age Corrected Corrected forbmi fort/shbg (N = 223) (N = 198) NSd -0.14" NSd gree a consequence of the high BMI in elderly women (the correlation between age and BMI was p = 0.40, P < ), but a correlation of p = 0.26, P < 0.01 (Table 2) was still found after eliminating the effect of BMI. No correlation was found between facial hirsutism and the T /SHBG ratio when the effect of the higher T/SHBG ratio in obese women 7 was eliminated (Table 3). There was only a weak relationship between the hirsutism score on trunk area and BMI (p = 0.16, P < 0.05, Table 1). It appeared to be a consequence of the higher androgenicity in obese women, 7 as no correlation could be found after adjusting for the T/SHBG ratio. Similarily, the negative correlation between the grade of hirsutism on trunk area and age (p = -0.21, P < 0.01, Table 2) was associated to the decrease in serum androgens 7 by age. The excessive hair growth on trunk area was correlated to the T/SHBG ratio (p = 0.35, P <, Table 3). Table 1 The Correlations (Simple and Partial Corrected for the Effect of the Age and the Testosterone/Sex Hormone Binding Globulin [T/SHBG] ratio) Between the Hair Growth and the Body Mass Index (BMI) Hirsutism score Face Trunk Total Simple (N = 223) 0.41" 0.16" 0.27c p < b p < c p <. d NS, not significant. BMI Corrected for age (N = 223) C 262 Ruutiainen et al. Hirsutism, weight and age Corrected fort/shbg (N = 198) 0.41" NSd 0.20b Table 3 The Correlations (Simple and Partial Corrected for the Body Mass Index [BMI] and for the Age) Between the Hair Growth and the Testosterone/Sex Hormone-Binding Globulin (T/SHBG) Ratio T/SHBG Corrected Corrected Hirsutism Simple forbmi for age score (N = 198) (N = 198) (N = 198) Face 0.21" NS 0.29b Trunk 0.35b 0.26b 0.29b Total 0.32b 0.21" 0.29b p < b p <. NS, not significant. Fertility and Sterility
4 Table 4 The Differences in the BMI, Age, and Menarche Between Two Hirsute Patient Groups ( <4)a Hirsutism score Face Trunk Total Age (yr) BMI Max. weight (kg) Teenage obesity Menarche ~Mage Oligomenorrhea(%) Facial score~ 4 (n = 89) 5.4 ± ± ± ± ± ± ± ± ± Facial score < 4 (n = 114) 1.4 ± ± ± ± ± ± ± ± ± P< NSb O.ol NS 0.05 NS a The differences in testosterone (T), androstendione, sex hromone-binding globulin (SHBG), the T/SHBG ratio, estradiol, and the LH/FSH ratio were not significant. The dehydroepiandrosterone sulfate values were slightly lower (P < 0.05) in the former group with a higher mean age. b NS, not significant. The effects of BMI and age on this correlation were weak. When the women with severe facial hair growth (hirsutism score on face ~ 4.0, the groups A+ B) were compared to the other hirsute patients (facial score < 4.0) there was a significant difference in BMI (P < ) and in the maximum weight (P <, Table 4) between the groups. Teenage obesity was also more common (P < 0.01) in women with severe versus mild or absent facial hirsutism. Moreover, there was a significant difference in the age (P < ) between these two patient groups (Table 4). No difference was found in the age of menarche. However, when taking into account the decline of the menarcheal age since the beginning of the century (~ M age), it appeared that the women with severe facial hirsutism had an earlier menarche compared with their agemates. The two groups with different localization of the excessive hair growth were similar in terms of their current hormonal values. When comparing the groups A, B, and C, the patients with facial hirsutism (groups A and B) had a higher BMI (P < 0.01) and maximum weight (P < 0.01) than the women with hirsutism concentrated only on the trunk area (Group C, Table 5). The groups B and C differed from each other in terms of their teenage obesity (P < 0.05, Table 5). The patients with pure facial hirsutism (group A) had an earlier menarche (P < 0.05) and~ Mage (P < 0.01) than the women in groups B and C (Table 5). The women in group B who had the highest total hirsutism score were more often oligomenorrheic than the women in group A (P < 0.05, Table 5). The hormone values were similar in all three patient groups. DISCUSSION The results of the present study indicate a close relationship between facial hirsutism and obesity. This is in agreement with the analysis of questionnaires obtained from more than 26,000 premenopausal females 9 : the women who considered themselves hirsute concerning the face and possibly Table 5 The Differences in the BMI, Age, and Menarche Between Three Patient Groups with Pure Facial Hirsutism (Group A, n = 35), with Hirsutism Both on the Face and on the Trunk (Group B, n = 54) and with Hirsutism Concentrated only on the Trunk (Group C, n = 26)a Group A Group B Group C A-B A-C B-C P< P< P< Hirsutism score Face 5.3 ± ± 1.4 Trunk 2.7 ± ± 3.6 Total 10.6 ± ± 5.1 Age (yr) 36.1 ± ± 7.7 BMI 27.0 ± ± 6.9 Max. weight (kg) 86.3 ± ± 18.7 Teenage obesity 1.8 ± ± 0.8 Menarche (yrs) 12.2 ± ± 1.3 ~Mage -0.9± ± 1.3 Oligomenorrhea(%) a The differences in testosterone (T), androstendione, sex hormone-binding globulin (SHBG), the T/SHBG ratio, and the LH/FSH ratio were insignificant. The dehydroepiandrosterone sulfate values were slightly lower in group A than in group C (P 1.4 ± 1.0 NSb 10.2 ± 1.9 NS 15.8 ± ± ± 4.4 NS ± 12.7 NS O.ol O.ol 1.3 ± 0.6 NS NS ± NS +0.3 ± NS NS NS < 0.05), and the estradiol values slightly higher in group B than in group C (P < 0.05). b NS, not significant. Vol. 50, No.2, August 1988 Ruutiainen et al. Hirsutism, weight and age 263
5 other areas were 4 kg heavier than the women who considered themselves normal. The association between facial hirsutism and body mass was also seen in the present work when comparing the groups with severe versus mild facial hair growth: the former had a higher mean of maximum weight and more teenage obesity. Hartz et al. 9 noticed that excess facial hair was associated with previous obesity even after adjusting for present obesity. We found that the significant positive correlation between facial hair and BMI was independent of the current grade of hyperandrogenemia. On the other hand, the positive correlation between facial hirsutism and the T /SHBG ratio appeared to be a consequence of a higher T /SHBG ratio in obese women, 7 and we could not find any relationship between facial hairiness and the grade of hyper androgenemia after adjusting the correlation for the effect of BMI. The correlation of the facial hair growth to current and previous overweight could be due to metabolic alterations associated primarily with obesity. On the other hand, obesity, heaviness before menarche, and hirsutism are features of PCOD, and the relationship between hirsutism and overweight does not necessarily imply a causalship. Facial hirsutism appears to be significantly associated with age, too, despite the decline in the serum androgen values during aging. 7 When one possible contributing factor, the effect of a high BMI in elderly women, is eliminated, facial hirsutism and age do still relate. Formerly, also Ferriman and Gallwey 10 noticed that hair tended to increase on the face and disappear from other sites with advancing years. They did not, however, calculate the statistical significance of the change in the hairiness. Neither did they study whether this was an independent aging phenomenon or secondarily associated with changes in serum androgens or incidence of obesity. Although most hirsute women overproduce a variety of active androgens, the expression of androgen action is modulated by peripheral tissue events. The enzyme Sa-reductase (5a-R) converts T to dihydrotestosterone (DHT), which mediates androgen action in the target tissues. The 5a-R activity is stimulated by androgens 16 in some skin areas. Once the enzyme becomes activated, it remains sensitive to low androgen levels for its life cycle. 17 It has been suggested that the increase in 5a-R in some normoandrogenemic hirsute patients might be due to an enzyme induction by hyperandrogenemia at puberty. 18 Also facial hair is dependent on the 5a-R activity since the male patients with 5a-R deficiency hermaphroditismus have absent facial hair in spite of partial signs of virilism in puberty. 19 Direct studies on the 5a-R activity on facial area and its dependency on androgens have not yet been published. Changes in enzyme activity and peripheral androgen metabolism might explain the correlation of facial hair growth with obesity and age in spite of the natural decline in serum androgen values. This could be one possible reason for the confusing clinical picture of virile hair growth on face in normoandrogenemic patients. It remains, however, to be studied whether aging phenomena independent of androgen action could increase the facial coarse terminal hair classically considered androgen dependent. The hirsutism on the trunk area was strongly associated with the T /SHBG ratio even after elimination of the effect of BMI. In contrast to facial hirsutism, the hair growth in trunk region does not correlate with age, and it has only a weak positive correlation with BMI. Moreover, this relationship was found to be associated with the higher levels of biologically active T in obese patients 7 because the correlation was not significant after adjusting it for the T/SHBG ratio. Formerly, Hartz et al. 9 were also unable to find evidence that women with virile hair growth other than on the face would be significantly heavier than normal women. The results might be explained by differences in the local androgen sensitivity or in the duration of the enzyme activation between face and trunk regions. The latter hypothesis is supported by a patient case of our own clinic: a 21-year-old woman was operated on in 1981 because of a rapidly virilizing neoplasm in her left adrenal. Postoperatively, the very high levels of serum androgens, especially T and DHEAS, were normalized, and the virile hair growth on trunk area disappeared in a few months. However, the severe facial hirsutism (Ferriman-Gallwey scale of 7) still persists 5 years after the operation. It appeared in our study that the women with severe facial hirsutism had a relatively earlier menarche than the other hirsute patients. The differences in the menarcheal age between the patient groups might reflect differences in body mass development in adolescence, as childhood obesity is associated with early menarche Childhood obesity is also associated with menstrual disturbancies, 21 and obese adolescent girls with irregular menses have been shown to have 264 Ruutiainen et al. Hirsutism, weight and age Fertility and Sterility
6 hormonal changes similar to those in PCOD. 22 In the present study, the only significant difference in the current menstrual patterns of the different patient groups was a high number of oligomenorrheic patients in the group with the highest total hirsutism score. Unfortunately, the design of our work does not allow us to answer the question if these patients had more menstrual abnormalities already in their adolescence. In summary, facial hirsutism is associated to obesity and aging irrespecively of the current T I SHBG ratio. On the contrary, the excessive hair growth in the trunk region correlates to the T I SHBG ratio but not with BMI or age when adjusted for the grade of hyperandrogenemia. The differences in the hair growth between the face and trunk regions need further evaluation. REFERENCES 1. Bardin CW, Lipsett MB: Testosterone and androstendione blood production rates in normal women, with idiopathic hirsutism and polycystic ovaries. J Clin Invest 46:891, Ruutiainen K, Erkkola R, Kaihola H-L, Santti R: The grade of hirsutism correlated to serum androgen levels and hormonal indices. Acta Obstet Gynecol Scand 64:629, Hosseinian AH, Kim MH, Rosenfield RL: Obesity and oligomenorrhea are associated with hyper androgenism independent of hirsutism. J Clin Endocrinol Metab 42:765, Samojlik E, Kirschner MA, Silber D, Schneider G, Ertel NH: Elevated production and metabolic clearance rates of androgens in morbidly obese women. J Clin Endocrinol Metab 59:949, Kopelman PG, Pilkington TRE, White N, Jeffcoate SL: Abnormal sex steroid secretion and binding in massively obese women. Clin Endocrinol12:363, Zhang Y, Stern B, Rebar RW: Endocrine comparison of obese menstruating and amenorrheic women. J Clin Endocrinol Metab 58:1077, Ruutiainen K, Erkkola R, Gronroos MA, Irjala K: Androgen parameters in hirsute women: correlations with body mass index and age. Fertil Steril 50:255, Kirschner MA, Samojlik E, Silber D: A comparison of androgen production and clearance in hirsute and obese women. J Steroid Biochem 19:607, Hartz AJ, Barboriak PN, Wong A, Katayama KP, Rimm AA: The association of obesity with infertility and related menstrual abnormalities in women. Int J Obes 3:57, Ferriman D, Gallwey JD: Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 24:1440, Thomas AE, McKay DA, Cutlip MB: A nomograph method for assessing body weight. Am J Clin Nutr 29:302, Widholm 0, Kantero R-L: A statistical analysis ofthe menstrual patterns of 8000 Finnish girls and their mothers. Acta Obstet Gynecol Scand 30(Suppl14):7, Heineman MJ, Thomas CMG, Doesburg WH, Rolland R: Hormonal characteristics of women with clinical features of the polycystic ovary syndrome. Eur J Obstet Gynec Reprod Bioi 17:263, Shirahata S: Tests of partial correlation in a linear model. Biometrika 64:162, Shirahata S: Rank tests of partial correlation. Bull Mathern Statistics 19:9, Mowszowicz I, Kirchhoffer MO, Kuttenn F, Mauvais-Jarvis P: Dihydrotestosterone stimulates 5a-reductase activity in pubic skin fibroblasts (PSF). J Clin Endocrinol Metab 56:320, Thomas JP, Oake RJ: Androgen metabolism in the skin of the hirsute women. J Clin Endocrinol Metab 38:19, Mauvais-Jarvis P: Regulation of androgen receptor and 5areductase in the skin of normal and hirsute women. Clin Endocrinol Metab 15:307, Imperato-McGinley J: The syndromes in male pseudohermaphroditism and 5a-reductase deficiency. In Regulation of androgen action, Edited by N Bruchovsky, A Chapdelaine, F Neumann. Berlin (West), R Brucner, 1985, p Frisch RE, Revelle R: Height and weight at menarche and a hypothesis of menarche. Arch Dis Child 46:695, Yen SSC: The polycystic ovary syndrome. Clin Endocrinol (OxO 12:117, Kaufman ED, Mosman J, Sutton M: Characterization of basal estrogen and androgen levels and gonadotropin release patterns in the obese adolescent females. J Pediatr 98:990, 1981 Vol. 50, No.2, August 1988 Ruutiainen et al. Hirsutism, weight and age 265
Risto Erkkola, M.D.t Kerttu Irjala, M.D. Kristiina Ruutiainen, M.D.tll
FRTILITY AND STRILITY Copyright e 199 The American Fertility Society Vol. 58, No.4, October 199 Printed on acid-free paper in U.S.A. Serum androgen and gonadotropin levels decline after progestogeninduced
More informationEndocrinologic features of oligomenorrheic adolescent girls*
FERTILITY AND STERILITY Copyright 1986 The American Fertility Society Printed in U.SA. Endocrinologic features of oligomenorrheic adolescent girls* Rita Siegberg, M.D. t Carl Gustaf Nilsson, M.D. Ulf-Hakan
More informationPolycystic Ovarian Syndrome (PCOS) LOGO
Polycystic Ovarian Syndrome (PCOS) Ma qianhong Ob/Gyn Department LOGO Contents Epidemiology and Definition Pathophysiology, Endocrinological Features Diagnostic Criteria Treatment Prognosis Introduction
More informationCase. 24 year old female presented to your office complaining of excess hair growth on her face and abdomen. Questions?
Hirsutism Case 24 year old female presented to your office complaining of excess hair growth on her face and abdomen Questions? Started around puberty with gradual progression Irregular menstrual cycle
More informationROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)
ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU) In 1935, Stein and Leventhal described 7 women with bilateral enlarged PCO, amenorrhea or irregular menses, infertility and masculinizing
More informationDr Stella Milsom. Endocrinologist Fertility Associates Auckland. 12:30-12:40 When Puberty is PCO
Dr Stella Milsom Endocrinologist Fertility Associates Auckland 12:30-12:40 When Puberty is PCO Puberty or Polycystic Ovary Syndrome? Stella Milsom Endocrinologist Auckland DHB, University of Auckland,
More information12/13/2017. Important references for PCOS. Polycystic Ovarian Syndrome (PCOS) for the Family Physician. 35 year old obese woman
Polycystic Ovarian Syndrome (PCOS) for the Family Physician Barbara S. Apgar MD, MS Professor or Family Medicine University of Michigan Ann Arbor, Michigan Important references for PCOS Endocrine Society
More informationClinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes
POLYCYSTIC OVARY SYNDROME Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes Ettore Guastella, M.D., a Rosa Alba Longo, M.D., b and Enrico Carmina, M.D. b a Department
More informationPolycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018
Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018 Learning Objectives At the conclusion of this lecture, learners should: 1) Know the various diagnostic
More informationMETABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN MORPHOLOGY
Vuk Vrhovac University Clinic Dugi dol 4a, HR-10000 Zagreb, Croatia Original Research Article Received: February 18, 2010 Accepted: March 3, 2010 METABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN
More informationWEIGHT CHANGE AND ANDROGEN LEVELS DURING CONTRACEPTIVE TREATMENT OF WOMEN AFFECTED BY POLYCYSTIC OVARY
ENDOCRINE REGULATIONS, VOL. 40, 119-123, 2006 119 WEIGHT CHANGE AND ANDROGEN LEVELS DURING CONTRACEPTIVE TREATMENT OF WOMEN AFFECTED BY POLYCYSTIC OVARY J. VRBIKOVA, K. DVORAKOVA, M. HILL, L. STARKA Institute
More informationTreatment of hirsutism with a gonadotropin-releasing hormone agonist and estrogen replacement therapy*
Gynecology-endocrinology FERTILITY AND STERILITY Copyright 1994 The American Fertility Society Printed on acid-free paper in U S. A. Treatment of hirsutism with a gonadotropin-releasing hormone agonist
More informationEFFECT OF DEXAMETHASONE AND CLOMIPHENE CITRATE ON PERIPHERAL STEROID LEVELS AND OV ARIAN FUNCTION IN A HIRSUTE AMENORRHEIC PATIENT*
FERTILITY AND STERILITY Copyright 1976 The American Fertility Society Vol. 27, No, 6, June 1976 Printed in UB.A. EFFECT OF DEXAMETHASONE AND CLOMIPHENE CITRATE ON PERIPHERAL STEROID LEVELS AND OV ARIAN
More informationProlactin modulates peripheral androgen metabolism*
FERTILITY AND STERILITY Copyright 1986 The American Fertility Society Printed in USA, Prolactin modulates peripheral androgen metabolism* Paulo Serafini, M,D, t Rogerio A, Lobo, M,D,:j: Department of Obstetrics
More information16 YEAR-OLD OBESE FEMALE WITH OLIGOMENORRHEA
16 YEAR-OLD OBESE FEMALE WITH OLIGOMENORRHEA Katie O Sullivan, MD Adult/Pediatric Endocrinology Fellow University of Chicago ENDORAMA Thursday, September 4th, 2014 Disclosures No financial interests. Will
More information2-Hypertrichosis:- Hypertrichosis is the
Hirsutism And Virilization Hirsutism:- Is the development of androgen-dependent dependent terminal body hair in a woman in places in which terminal hair is normally not found, terminal body hairs are the
More informationIdiopathic hirsutism: an uncommon cause of hirsutism in Alabama
FERTILITY AND STERILITY VOL. 70, NO. 2, AUGUST 1998 Copyright 1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Idiopathic hirsutism:
More informationDaily blood hormone levels related to the luteinizing hormone surge in anovulatory cycles
FRTILITY AND STRILITY Copyright 1983 The American Fertility Society Printed in U.8A. Daily blood hormone levels related to the luteinizing hormone surge in anovulatory cycles Chung H. Wu, M.D. * F. Susan
More informationDiagnostic Performance of Serum Total Testosterone for Japanese Patients with Polycystic Ovary Syndrome
Endocrine Journal 2007, 54 (2), 233 238 Diagnostic Performance of Serum Total Testosterone for Japanese Patients with Polycystic Ovary Syndrome TAKESHI IWASA, TOSHIYA MATSUZAKI, MASAHIRO MINAKUCHI, NAOKO
More informationInvestigation of adrenal functions in patients with idiopathic hyperandrogenemia
European Journal of Endocrinology (26) 155 37 311 ISSN 84-4643 CLINICAL STUDY Investigation of adrenal functions in patients with idiopathic hyperandrogenemia Hulusi Atmaca, Fatih Tanriverdi 1, Kursad
More informationX/06/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 91(1):2 6 Copyright 2006 by The Endocrine Society doi: /jc.
0021-972X/06/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 91(1):2 6 Printed in U.S.A. Copyright 2006 by The Endocrine Society doi: 10.1210/jc.2005-1457 EXTENSIVE CLINICAL EXPERIENCE Relative
More informationSAMPLE REPORT. Order Number: PATIENT. Age: 40 Sex: F MRN:
Patient: Age: 40 Sex: F MRN: SAMPLE PATIENT Order Number: Completed: Received: Collected: SAMPLE REPORT Progesterone ng/ml 0.34 0.95 21.00 DHEA-S mcg/dl Testosterone ng/ml 48 35 0.10 0.54 0.80 430 Sex
More informationRelation of luteinizing hormone levels to body mass index in premenopausal women
FERTILITY AND STERILITY VOL. 69, NO. 3, MARCH 1998 Copyright 1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Relation of luteinizing
More informationLaura Stewart, MD, FRCPC Clinical Associate Professor Division of Pediatric Endocrinology University of British Columbia
Precocious Puberty Laura Stewart, MD, FRCPC Clinical Associate Professor Division of Pediatric Endocrinology University of British Columbia Faculty Disclosure Faculty: Laura Stewart No relationships with
More informationTitle of Guideline (must include the word Guideline (not protocol, policy, procedure etc)
Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Guideline for the Investigation and Management of Polycystic Ovary Syndrome Author: Contact Name and Job Title
More informationHirsutism: Diagnosis and Treatment. Roger A. Lobo M.D. Columbia University
Hirsutism: Diagnosis and Treatment Roger A. Lobo M.D. Columbia University Signs of hyperandrogenism Acne, Hirsutism, Alopecia All explained by increased androgen production and/or increased sensitivity
More informationReproductive FSH. Analyte Information
Reproductive FSH Analyte Information 1 Follicle-stimulating hormone Introduction Follicle-stimulating hormone (FSH, also known as follitropin) is a glycoprotein hormone secreted by the anterior pituitary
More informationProf.Dr. Nabil Lymon Head of Internal Medicine Department
By Prof.Dr. Nabil Lymon Head of Internal Medicine Department Definitions: Hirsutism: Is the presence of terminal hair in androgendependent sites where hair does not normally grow in women. This hair growth
More informationDetermining the insulin resistance rate in Polycystic Ovary Syndrome patients (PCOs)
Abstract: Determining the insulin resistance rate in Polycystic Ovary Syndrome patients (PCOs) Ashraf Olabi, Ghena Alqotini College of medicine, Aleppo University Hospital Obstetrics and Gynacology, Syria.
More informationReproductive outcome in women with body weight disturbances
Reproductive outcome in women with body weight disturbances Zeev Shoham M.D. Dep. Of OB/GYN Kaplan Hospital, Rehovot, Israel Weight Status BMI (kg/m 2 ) Underweight
More informationEFFECT OF WEIGHT LOSS ON OVARIAN AND ADRENAL ANDROGEN SENSITIVITY. Department OB/GYN. EVMA Norfolk, Va Telephone: (804)
This study predates but predicts the use of glucophage, exercise and diet for the treatment of PCO. EFFECT OF WEIGHT LOSS ON OVARIAN AND ADRENAL ANDROGEN SENSITIVITY Principal Investigator: Hofheimer Hall
More informationThe prognostic value of acute adrenal suppression and stimulation tests in hyperandrogenic women
FERTUJTY AND STERILITY Copyright c 1982 The American Fertility Society Vol. 37, No.2, February 198~ Printed in U.SA. The prognostic value of acute adrenal suppression and stimulation tests in hyperandrogenic
More informationGynecology-endocrinology
Gynecology-endocrinology FERTILITY AND STERILITY Copyright (fj 1991 The American Fertility Society Vol. 55, No, 5, May 1991 Printed on acid-free paper in U.S.A. Serum androsterone conjugates differentiate
More informationWHY NEW DIAGNOSTIC CRITERIA FOR DIFFERENT PCOS PHENOTYPES ARE URGENTLY NEEDED
WHY NEW DIAGNOSTIC CRITERIA FOR DIFFERENT PCOS PHENOTYPES ARE URGENTLY NEEDED Ricardo Azziz, M.D., M.P.H., M.B.A. Chief Officer of Academic Health & Hospital Affairs State University of New York (SUNY)
More informationReproductive physiology
Reproductive physiology Sex hormones: Androgens Estrogens Gestagens Learning objectives 86 (also 90) Sex Genetic sex Gonadal sex Phenotypic sex XY - XX chromosomes testes - ovaries external features Tha
More informationFinasteride* in the treatment of hirsutism: new therapeutic perspectives
FERTILITY AND STERILI'fY Copyright 1996 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Finasteride* in the treatment of hirsutism: new therapeutic perspectives Achille
More informationSCREENING OF POLYCYSTIC OVARIAN SYNDROME AMONG ADOLESCENT GIRLS AT CAIRO UNIVERSITY
SCREENING OF POLYCYSTIC OVARIAN SYNDROME AMONG ADOLESCENT GIRLS AT CAIRO UNIVERSITY Sahar Mansour Ibrahim, Yossria Ahmed Elsayed, Reda Esmail Reyad 4 and Hanan Fahmy Azzam 1* 2 3 1 Assistant Lecturer,
More informationSalivary Versus Serum Approaches in Assessment of Biochemical Hyperandrogenemia
Original Article Salivary Versus Serum Approaches in Assessment of Biochemical Hyperandrogenemia Mohamed Nabih El Gharib, Sahar Mohey El Din Hazaa 1 Departments of Obstetrics and Gynecology, and 1 Clinical
More informationGONADAL FUNCTION: An Overview
GONADAL FUNCTION: An Overview University of PNG School of Medicine & Health Sciences Division of Basic Medical Sciences Clinical Biochemistry BMLS III & BDS IV VJ Temple 1 What are the Steroid hormones?
More informationPolycystic Ovary Syndrome
Polycystic Ovary Syndrome Definition: the diagnostic criteria Evidence of hyperandrogenism, biochemical &/or clinical (hirsutism, acne & male pattern baldness). Ovulatory dysfunction; amenorrhoea; oligomenorrhoea
More informationPrevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai
Prevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai Principal Investigator Co- Investigators Consultant Collaborating Hospital Dr. Beena Joshi Dr. Srabani Mukherji
More informationNitasha Garg 1 Harkiran Kaur Khaira. About the Author
https://doi.org/10.1007/s13224-017-1082-4 ORIGINAL ARTICLE A Comparative Study on Quantitative Assessment of Blood Flow and Vascularization in Polycystic Ovary Syndrome Patients and Normal Women Using
More informationThe contributions of oestrogen and growth factors to increased adrenal androgen secretion in polycystic ovary syndrome
Human Reproduction vol.14 no.2 pp.307 311, 1999 The contributions of oestrogen and growth factors to increased adrenal androgen secretion in polycystic ovary syndrome E.Carmina 1, F.Gonzalez 2, A.Vidali
More informationEpidemiologic and etiologic aspects of hirsutism in Kashmiri women in the Indian subcontinent
FERTILITY AND STERILITY VOL. 77, NO. 4, APRIL 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Epidemiologic and etiologic
More informationPolycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks
Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks Kate D. Schoyer, M.D. May 6, 2016 Objectives To review how to make the diagnosis of Polycystic Ovarian Syndrome (PCOS)
More informationThe prevalence of polycystic ovaries in healthy women
Acta Obstet Gynecol Scand 1999; 78: 137 141 Copyright C Acta Obstet Gynecol Scand 1999 Printed in Denmark all rights reserved Acta Obstetricia et Gynecologica Scandinavica ISSN 0001-6349 ORIGINAL ARTICLE
More informationClinical Guideline ADRENARCHE MANAGEMENT OF CHILDREN PRESENTING WITH SIGNS OF EARLY ONSET PUBIC HAIR/BODY ODOUR/ACNE
Clinical Guideline ADRENARCHE MANAGEMENT OF CHILDREN PRESENTING WITH SIGNS OF EARLY ONSET PUBIC HAIR/BODY ODOUR/ACNE Includes guidance for the distinction between adrenarche, precocious puberty and other
More informationIMPACT OF NUTRITION ON GYNECOLOGICAL HEALTH OF FEMALE ADOLESCENTS
IMPACT OF NUTRITION ON GYNECOLOGICAL HEALTH OF FEMALE ADOLESCENTS Kedikova S. MD, PhD Medical University Sofia, Bulgaria University Hospital Maichin dom Sofia NUTRITION WHO - Nutrition is the intake of
More informationCase Questions. Polycystic Ovarian Syndrome: Treatment Goals and Options. Differential Diagnosis of Hyperandrogenic Anovulation
Polycystic Ovarian Syndrome: Treatment Goals and Options Marc Cornier, MD Division of Endocrinology, Metabolism and Diabetes Colorado Center for Health and Wellness University of Colorado School of Medicine
More informationPolycystic Ovary Syndrome Therapy Dr. Pilar Vigil MD, PhD, FACOG
Polycystic Ovary Syndrome Therapy Dr. Pilar Vigil MD, PhD, FACOG What is an ovulatory dysfunction? Mrs. Susana Godoy, Nurse-Midwife San José, Costa Rica Abril 2018 PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE
More informationDifferential response to adrenocorticotropin hormone stimulation in polycystic ovarian disease with high and low dehydroepiandrosterone sulfate levels
FERTILITY AND STERILITY Copyright C> 1982 The American Fertility Society PrintmJ. in U.SA. Differential response to adrenocorticotropin hormone stimulation in polycystic ovarian disease with high and low
More informationMetfornim and Pioglitazone in polycystic ovarian syndrome: A comparative study
Original Research Article Metfornim and Pioglitazone in polycystic ovarian syndrome: A comparative study Allanki Suneetha Devi 1, Jalem Anuradha 2* 1 Associate Professor, Department of Obstetrics and Gynecology,
More informationAbnormal Uterine Bleeding Case Studies
Case Study 1 Abnormal Uterine Bleeding Case Studies Abigail, a 24 year old female, presents to your office complaining that her menstrual cycles have become a problem. They are now lasting 6 7 days instead
More informationPolycystic Ovary Syndrome (PCOS):
Polycystic Ovary Syndrome (PCOS): Current diagnosis and treatment Anatte E. Karmon, MD Disclosures- Anatte Karmon, MD No financial relationships to disclose 2 Objectives At the end of this presentation,
More informationAwareness of PCOS (polycystic ovarian syndrome) in adolescent and young girls
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Upadhye JJ et al. Int J Reprod Contracept Obstet Gynecol. 2017 Jun;6(6):2297-2301 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20172119
More informationOverview of Reproductive Endocrinology
Overview of Reproductive Endocrinology I have no conflicts of interest to report. Maria Yialamas, MD Female Hypothalamic--Gonadal Axis 15 4 Hormone Secretion in the Normal Menstrual Cycle LH FSH E2, Progesterone,
More informationThe Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (1), Page 63-69
The Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (1), Page 63-69 Effect of Metformin Only versus Effect of Metformin and Corticosteroids after Laparoscopic Ovarian Drilling on Ovulation
More informationPolycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks. Kate D. Schoyer, M.D. May 6, 2016
Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks Kate D. Schoyer, M.D. May 6, 2016 Objectives To review how to make the diagnosis of Polycystic Ovarian Syndrome (PCOS)
More informationPrevalence and hormonal profile of polycystic ovary syndrome in young Kashmiri women presenting with hirsutism: A hospital based study
Original Article Prevalence and hormonal profile of polycystic ovary syndrome in young Kashmiri women presenting with hirsutism: A hospital based study Majid Jahangir, MD 1 Seema Qayoom, MD ² Peerzada
More informationPCOS and Obesity DUB is better treated by OCPs
PCOS and Obesity DUB is better treated by OCPs Dr. Ritu Joshi Senior consultant Fortis escorts Hospital, Jaipur Chairperson Family welfare com. FOGSI (20092012) Vice President FOGSI 2014 Introduction One
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/69827
More informationSemih Tugrul, M.D., Tayfun Kutlu, M.D., Oya Pekin, M.D., Elif Baglam, M.D., H useyin Kıyak, M.D., and Ozay Oral, M.D.
Clinical, endocrine, and metabolic effects of acarbose, a a-glucosidase inhibitor, in overweight and nonoverweight patients with polycystic ovarian syndrome Semih Tugrul, M.D., Tayfun Kutlu, M.D., Oya
More informationSCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY
1 SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY PBL SEMINAR: SEX HORMONES PART 1 An Overview What are steroid hormones? Steroid
More informationHormonal Control of Human Reproduction
Hormonal Control of Human Reproduction Bởi: OpenStaxCollege The human male and female reproductive cycles are controlled by the interaction of hormones from the hypothalamus and anterior pituitary with
More informationFrank Gonzalez, M.D.,* Lillie Chang, M.D., Theresa Horab, R.N.,* Frank Z. Stanczyk, Ph.D., Kent Crickard, M.D.,* and Rogerio A. Lobo, M.D.
FERTILITY AND STERILITY VOL. 71, NO. 3, MARCH 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Adrenal dynamic responses
More informationMetformin and Pioglitazone in Polycystic Ovarian Syndrome: A Comparative Study
The Journal of Obstetrics and Gynecology of India (September-October 2012) 62(5):551 556 DOI 10.1007/s13224-012-0183-3 ORIGINAL ARTICLE Metformin and Pioglitazone in Polycystic Ovarian Syndrome: A Comparative
More informationGonadotrophin treatment in patients with Polycystic Ovary Syndrome
Int. J. Adv. Res. Biol. Sci. (218). 5(4): 95-99 International Journal of Advanced Research in Biological Sciences ISSN: 2348-869 www.ijarbs.com DOI: 1.22192/ijarbs Coden: IJARQG(USA) Volume 5, Issue 4-218
More informationHyperandrogenism. Dr Jack Biko. MB. BCh (Wits), MMED O & G (Pret), FCOG (SA), Dip Advanced Endoscopic Surgery(Kiel, Germany)
Hyperandrogenism Dr Jack Biko MB. BCh (Wits), MMED O & G (Pret), FCOG (SA), Dip Advanced Endoscopic Surgery(Kiel, Germany) 2012 Hyperandrogenism Excessive production of androgens Adrenal glands main source
More informationHormone. Free Androgen Index. 2-Hydroxyestrone. Reference Range. Hormone. Estrone Ratio. Free Androgen Index
Hormonal Health PATIENT: Sample Report TEST REF: TST-12345 Hormonal Health 0.61 0.30-1.13 ng/ml DHEA-S 91 35-430 mcg/dl tient: SAMPLE TIENT e: x: N: Sex Binding Globulin 80 18-114 nmol/l Testosterone 0.34
More informationMetformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome
FERTILITY AND STERILITY VOL. 69, NO. 4, APRIL 1998 Copyright 1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Metformin therapy improves
More informationDiagnosis and Management of Polycystic Ovary Syndrome During Adolescence: Questions and Controversies
Diagnosis and Management of Polycystic Ovary Syndrome During Adolescence: Questions and Controversies 2017 Illinois-AACE 2017 Annual Meeting October 14, 2017 Learning Objectives 1) Understand the challenges
More informationPOLYCYSTIC OVARY SYNDROME INA S. IRABON,MD, FPOGS,FPSRM,FPSGE OBSTETRICS AND GYNECOLOGY REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY
POLYCYSTIC OVARY SYNDROME INA S. IRABON,MD, FPOGS,FPSRM,FPSGE OBSTETRICS AND GYNECOLOGY REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY TO DOWNLOAD LECTURE DECK MAIN REFERENCE Comprehensive Gynecology 7 th
More informationNormal ovarian function in a mild form of late-onset
FERTILITY AND STERILITY Copyright ~ 1986 The American Fertility Society Printed in U.8A. Normal ovarian function in a mild form of late-onset 3~-hydroxysteroid dehydrogenase deficiency* Martha Medina,
More informationS. AMH in PCOS Research Insights beyond a Diagnostic Marker
S. AMH in PCOS Research Insights beyond a Diagnostic Marker Dr. Anushree D. Patil, MD. DGO Scientist - D National Institute for Research in Reproductive Health (Indian Council of Medical Research) (Dr.
More informationSelection criteria of normal controls to predict reliable cut-off values of various endocrine parameters in infertility
J Obstet Gynecol India Vol. 55, No. 1 : January/February 2005 Pg 72-76 ORIGINAL ARTICLE The Journal of Obstetrics and Gynecology of India Selection criteria of normal controls to predict reliable cut-off
More informationTHE RELATION BETWEEN PLASMA TESTOSTERONE LEVELS AND THE LENGTHS OF PHASES OF THE MENSTRUAL CYCLE*
FERTILITY AND STERILITY Copyright 1979 The American Fertility Society Vol. 32, No.4, October 1979 Printed in U.s.A. THE RELATION BETWEEN PLASMA TESTOSTERONE LEVELS AND THE LENGTHS OF PHASES OF THE MENSTRUAL
More informationFemale Reproductive Endocrinology
Female Reproductive Endocrinology Dr. Channa Jayasena PhD MRCP FRCPath Clinical Senior Lecturer & Consultant Endocrinologist Department of Gynaecology, Hammersmith Hospital Anovulation is a common cause
More informationThe Effect of Vitamin D Replacement Therapy on Serum Leptin and Follicular Growth Pattern in Women with Clomiphene Citrate Resistant Polycystic Ovary
Med. J. Cairo Univ., Vol. 84, No. 2, June: 85-89, 2016 www.medicaljournalofcairouniversity.net The Effect of Vitamin D Replacement Therapy on Serum Leptin and Follicular Growth Pattern in Women with Clomiphene
More informationAchieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center
Achieving Pregnancy: Obesity and Infertility Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center Disclosures Speakers Bureau EMD Serono Board of Directors Nurse
More informationClinical Profile Polycystic Ovarian Syndrome Cases
ORIGINAL RESEARCH www.ijcmr.com - 100 Cases Himabindu Sangabathula 1, Neelima Varaganti 1 ABSTRACT Introduction: Polycystic ovary syndrome (PCOS) is most common endocrine disorders of reproductive age
More informationPCOS IN ADOLESCENTS: EARLY DETECTION AND INTERVENTION
PCOS IN ADOLESCENTS: EARLY DETECTION AND INTERVENTION R A C H A N A S H A H, M D M S T R A S S I S TA N T P R O F E S S O R O F P E D I AT R I C S D I V I S I O N O F E N D O C R I N O L O G Y A N D D
More informationPolycystic Ovarian Syndrome. Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology
Polycystic Ovarian Syndrome Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology Outline Definition Symptoms Causal factors Diagnosis Complications Treatment Why are we talking about
More informationclinical outcome and hormone profiles before and after laparoscopic electroincision of the ovaries in women with polycystic ovary syndrome
& clinical outcome and hormone profiles before and after laparoscopic electroincision of the ovaries in women with polycystic ovary syndrome Zulfo Godinjak¹*, Ranka Javorić² 1 Gynecology and Obstetrics
More informationREI CASE(S) Laura L. Tatpati, MD Division of REI, Dept of OB/GYN KUSM - W
REI CASE(S) Laura L. Tatpati, MD Division of REI, Dept of OB/GYN KUSM - W CASE #1 46 year old female presents with complaint of increased facial and abdominal hair growth for 6-8 months. She has had increased
More informationPolycystic Ovary Syndrome
What is the polycystic ovary syndrome? Polycystic Ovary Syndrome The polycystic ovary syndrome (PCOS) is a clinical diagnosis characterized by the presence of two or more of the following features: irregular
More informationBy Jennifer F. Teskey, MD; Heather J. Dean, MD, FRCPC; and Elizabeth AC Sellers, MSc, MD, FRCPC. amenorrhea. Following menarche 3. How to treat PCOS.
PCOS & teens: The need for early detection By Jennifer F. Teskey, MD; Heather J. Dean, MD, FRCPC; and Elizabeth AC Sellers, MSc, MD, FRCPC A 15-year-old girl is referred In this article: to the pediatric
More informationPolycystic Ovary Syndrome
Polycystic Ovary Syndrome Kathleen Colleran, MD Professor of Medicine University of New Mexico HSC Presented for COMM-TC May 4, 2012 Objectives Understand the pathophysiology of PCOS Understand how to
More informationINSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview
INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview University of PNG School of Medicine & Health Sciences Division of Basic Medical Sciences PBL MBBS III VJ Temple 1 Insulin Resistance: What is
More informationTESTOSTERONE DEFINITION
DEFINITION A hormone that is a hydroxyl steroid ketone (C19H28O2) produced especially by the testes or made synthetically and that is responsible for inducing and maintaining male secondary sex characteristics.
More informationKey words: polycystic ovary syndrome, hypothalmic-pituitary-ovarian axes
Clin Pediatr Endocrinol 1999; 8(2), 77-84 Copyright 1999 by The Japanese Society for Pediatric Endocrinology Clinical, Hormonal, and Radiological Studies at Baseline, During and After Long Term GnRH Analog
More informationEvaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society* Clinical Practice Guideline
CLINICAL PRACTICE GUIDELINE Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society* Clinical Practice Guideline Kathryn A. Martin, 1 R. Rox Anderson, 1 R. Jeffrey Chang, 2 David
More informationThe prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria
Prace oryginalne/original papers Endokrynologia Polska/Polish Journal of Endocrinology Tom/Volume 62; Numer/Number 3/2011 ISSN 0423 104X The prevalence of polycystic ovary syndrome in Iranian women based
More informationRisk of Developing Polycystic Ovarian Syndrome- Adolescent Girls
Open Access Journal Research Article DOI: 1.98/ijirms/vol-i/ Risk of Developing Polycystic Ovarian Syndrome- Adolescent Girls Satyajit Assistant Professor, Shri Guru Ram Dass College of Nursing, Hoshiarpur
More informationInternational Journal of Advanced Research in Biological Sciences ISSN : Research Article
International Journal of Advanced Research in Biological Sciences ISSN : 2348-8069 www.ijarbs.com Research Article Tamoxifen or Drospirenone and Ethinyl Estradiol: which is the first choice for infertile
More informationThe role of FSH, LH, and Prolactin Hormones in Female Infertility
RESEARCH ARTICLE Am. J. PharmTech Res. 2016; 6(5) ISSN: 2249-3387 CX The role of FSH, LH, and Prolactin Hormones in Female Infertility ABSTRACT Journal home page: http://www.ajptr.com/ Ali A. Al-Fahham
More informationAmenorrhoea: polycystic ovary syndrome
There is so much we don't know in medicine that could make a difference, and often we focus on the big things, and the little things get forgotten. To highlight some smaller but important issues, we've
More informationThe serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins
Original Article Obstet Gynecol Sci 2018;61(2):242-246 https://doi.org/10.5468/ogs.2018.61.2.242 pissn 2287-8572 eissn 2287-8580 The serum estradiol/oocyte ratio in patients with breast cancer undergoing
More informationAN AETIOLOGICAL STUDY OF MODERATE TO SEVERE HIRSUTISM
Original Article AN AETIOLOGICAL STUDY OF MODERATE TO SEVERE HIRSUTISM Lamees Mahmood Malik 1, Khawar Khursheed 2,Tahir Saeed Haroon 3, Mahmood Ali Malik 4 ABSTRACT Objective: Hirsutism is a common disorder
More informationPrevalence of and markers for the attenuated form of congenital adrenal hyperplasia and hyperprolactinemia masquerading as polycystic ovarian disease*
FERTILITY AND STERILITY Copyright" 1986 The American Fertility Society Vol. 46, No.2, August 1986 Printed in U.8A. Prevalence of and markers for the attenuated form of congenital adrenal hyperplasia and
More informationEndocrine features of polycystic ovary syndrome in a random population sample of year old adolescents
Human Reproduction vol.14 no.9 pp.2223 2229, 1999 Endocrine features of polycystic ovary syndrome in a random population sample of 14 16 year old adolescents M.H.A.van Hooff 1,5, F.J.Voorhorst 2, M.B.H.Kaptein
More information